Temporary Anticoagulation Interruption
Cross-source consensus on Temporary Anticoagulation Interruption from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Dosage & preparation
Risks & contraindications
Evidence quality
Highlighted claims
- The control arm temporarily suspends anticoagulation according to the 2021 BSG and ESGE guideline. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- Dosing changes in the temporary interruption arm depend on thrombotic risk. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- European guidance currently recommends temporary anticoagulant suspension for polypectomy, but the article characterises the supporting evidence as low quality. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- Temporary anticoagulation suspension can increase thromboembolic risk even in patients considered low risk. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM